BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,126,696 | -14.2% | 294,825 | +3.6% | 0.05% | -8.0% |
Q2 2023 | $12,968,836 | +333.5% | 284,654 | +285.9% | 0.05% | +316.7% |
Q1 2023 | $2,991,624 | -18.8% | 73,758 | +2.0% | 0.01% | -20.0% |
Q4 2022 | $3,685,335 | +1.3% | 72,304 | +7.0% | 0.02% | -6.2% |
Q3 2022 | $3,639,000 | -52.9% | 67,561 | -43.9% | 0.02% | -48.4% |
Q2 2022 | $7,734,000 | -7.8% | 120,407 | +11.3% | 0.03% | +6.9% |
Q1 2022 | $8,386,000 | -10.1% | 108,156 | -0.5% | 0.03% | -14.7% |
Q4 2021 | $9,329,000 | +8.4% | 108,676 | +1.6% | 0.03% | -2.9% |
Q3 2021 | $8,603,000 | +1.0% | 106,968 | +1.1% | 0.04% | +2.9% |
Q2 2021 | $8,519,000 | -4.4% | 105,827 | +0.1% | 0.03% | -10.5% |
Q1 2021 | $8,915,000 | -9.4% | 105,703 | -13.8% | 0.04% | -17.4% |
Q4 2020 | $9,843,000 | +103.5% | 122,668 | +104.0% | 0.05% | +84.0% |
Q3 2020 | $4,836,000 | +27.6% | 60,130 | +36.6% | 0.02% | +13.6% |
Q2 2020 | $3,789,000 | +6.8% | 44,009 | +0.7% | 0.02% | -12.0% |
Q1 2020 | $3,549,000 | -8.2% | 43,712 | -5.5% | 0.02% | +13.6% |
Q4 2019 | $3,867,000 | -5.8% | 46,247 | -1.4% | 0.02% | -8.3% |
Q3 2019 | $4,103,000 | -1.7% | 46,906 | -8.0% | 0.02% | -4.0% |
Q2 2019 | $4,176,000 | -13.5% | 50,993 | -14.1% | 0.02% | -16.7% |
Q1 2019 | $4,826,000 | +20.1% | 59,361 | -2.8% | 0.03% | 0.0% |
Q4 2018 | $4,018,000 | -15.9% | 61,051 | -1.5% | 0.03% | 0.0% |
Q3 2018 | $4,777,000 | +3.1% | 61,967 | -1.3% | 0.03% | +3.4% |
Q2 2018 | $4,634,000 | +14.5% | 62,757 | +0.9% | 0.03% | +11.5% |
Q1 2018 | $4,046,000 | -3.7% | 62,204 | -4.3% | 0.03% | 0.0% |
Q4 2017 | $4,203,000 | -1.4% | 65,020 | -4.3% | 0.03% | -3.7% |
Q3 2017 | $4,262,000 | +4.7% | 67,927 | +1.0% | 0.03% | -3.6% |
Q2 2017 | $4,072,000 | +16.4% | 67,276 | -0.2% | 0.03% | +16.7% |
Q1 2017 | $3,498,000 | +13.2% | 67,434 | -3.2% | 0.02% | +9.1% |
Q4 2016 | $3,089,000 | -7.3% | 69,676 | -0.8% | 0.02% | -12.0% |
Q3 2016 | $3,334,000 | -5.3% | 70,252 | -9.8% | 0.02% | -3.8% |
Q2 2016 | $3,522,000 | +11.7% | 77,884 | +1.4% | 0.03% | +8.3% |
Q1 2016 | $3,154,000 | +8.3% | 76,775 | +0.6% | 0.02% | 0.0% |
Q4 2015 | $2,913,000 | +16.1% | 76,352 | +0.0% | 0.02% | +20.0% |
Q3 2015 | $2,508,000 | -62.6% | 76,329 | -20.3% | 0.02% | -57.4% |
Q2 2015 | $6,699,000 | +1.2% | 95,795 | -0.8% | 0.05% | 0.0% |
Q1 2015 | $6,617,000 | -4.0% | 96,603 | +2.7% | 0.05% | +2.2% |
Q4 2014 | $6,895,000 | -9.7% | 94,083 | -11.6% | 0.05% | 0.0% |
Q3 2014 | $7,634,000 | -0.3% | 106,370 | +0.4% | 0.05% | +7.0% |
Q2 2014 | $7,657,000 | +10.3% | 105,909 | -2.2% | 0.04% | +4.9% |
Q1 2014 | $6,945,000 | -22.6% | 108,263 | -16.1% | 0.04% | -25.5% |
Q4 2013 | $8,969,000 | -8.7% | 128,963 | -13.7% | 0.06% | -12.7% |
Q3 2013 | $9,822,000 | -10.8% | 149,521 | -5.9% | 0.06% | -16.0% |
Q2 2013 | $11,006,000 | – | 158,899 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |